臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或输入年份:

从最近的开始

由旧到新排序

显示项目 2233526-2233550 / 2346973 (共93879页)
<< < 89337 89338 89339 89340 89341 89342 89343 89344 89345 89346 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-08-31T06:29:21Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:22Z	Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (British Journal of Cancer, (2019), 121, 3, (218-221), 10.1038/s41416-019-0506-6)	Evans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; ANN-LII CHENG; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W.
臺大學術典藏	2021-08-31T06:29:22Z	Potent activity of composite cyclin dependent kinase inhibition against hepatocellular carcinoma	Shao Y.-Y.; Li Y.-S.; Hsu H.-W.; Lin H.; Wang H.-Y.; Wo R.R.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:22Z	Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma	Lin Z.-Z.; Hsu C.; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Wu Y.-M.; Hsu H.-C.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:22Z	Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer	Chen Y.-H.; Wang C.-W.; Wei M.-F.; Tzeng Y.-S.; Lan K.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:23Z	Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness	Hsu C.-Y.; Wang C.-W.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:23Z	Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer	Price T.; Shen L.; Ma B.; Esser R.; Chen W.; Gibbs P.; Lim R.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:23Z	Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma	Evans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; ANN-LII CHENG; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W.
臺大學術典藏	2021-08-31T06:29:23Z	The APPLE Association Predident's Message	ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:23Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:24Z	Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma	Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; ANN-LII CHENG; Tzen K.-Y.; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:24Z	CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer	Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-08-31T06:29:24Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:24Z	Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Hsu P.-N.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:25Z	The APPLE association president's message	ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:25Z	Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma	Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; ANN-LII CHENG; Hsu C.
臺大學術典藏	2021-08-31T06:29:25Z	Phase I Study of the Focal Adhesion Kinase Inhibitor BI?853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors	Doi T.; Yang J.C.-H.; Shitara K.; Naito Y.; ANN-LII CHENG; Sarashina A.; Pronk L.C.; Takeuchi Y.; Lin C.-C.
臺大學術典藏	2021-08-31T06:29:25Z	Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer	Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; Chen T.W.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F.
臺大學術典藏	2021-08-31T06:29:26Z	The APPLE Association President's Message	ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:26Z	Corrigendum to ��Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies�� [J hepatol 67 (2017) 999�V1008](S0168827817321347)(10.1016/j.jhep.2017.06.026))	Bruix J.; ANN-LII CHENG; Meinhardt G.; Nakajima K.; De Sanctis Y.; Llovet J.
臺大學術典藏	2021-08-31T06:29:26Z	Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer	Chen W.-Y.; Wu C.-T.; Wang C.-W.; Lan K.-H.; Liang H.-K.; Huang B.-S.; Chang Y.-L.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:26Z	A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma	Yang S.-H.; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-08-31T06:29:27Z	Effect of glucocorticoid use on survival in patients with stage I�VIII breast cancer	Lin C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; Huang C.-S.; Wang M.-Y.; Chao M.; Lu Y.-S.; ANN-LII CHENG; Tang C.-H.
臺大學術典藏	2021-08-31T06:29:27Z	Cabozantinib in patients with advanced and progressing hepatocellular carcinoma	Abou-Alfa G.K.; Meyer T.; ANN-LII CHENG; El-Khoueiry A.B.; Rimassa L.; Ryoo B.-Y.; Cicin I.; Merle P.; Chen Y.; Park J.-W.; Blanc J.-F.; Bolondi L.; Kl?mpen H.-J.; Chan S.L.; Zagonel V.; Pressiani T.; Ryu M.-H.; Venook A.P.; Hessel C.; Borgman-Hagey A.E.; Schwab G.; Kelley R.K.
臺大學術典藏	2021-08-31T06:29:27Z	Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection	Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group

显示项目 2233526-2233550 / 2346973 (共93879页)
<< < 89337 89338 89339 89340 89341 89342 89343 89344 89345 89346 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2854037
	造访人次 : 45351533 在线人数 : 1733 教育部委托研究计画计画执行:国立台湾大学图书馆